In the last few years, immunotherapy has become an important cancer treatment modality,
and although the principles of immunotherapy have evolved over many decades, the FDA …

Leveraging the immune system to thwart cancer is not a novel strategy and has been
explored via cancer vaccines and use of immunomodulators like interferons. However, it …

Viruses and tumors are two pathologies that negatively impact human health, but what
occurs when a virus encounters a tumor? A global consensus among cancer patients …

In recent history, immunotherapy has become a viable cancer therapeutic option. However,
over many years, its tenets have changed, and it now comprises a range of cancer-focused …

Introduction Medical treatment for prostate cancer (PC) targets hormonal pathways used by
malignant cells. Research advances aided in gaining knowledge about implicated …

Prostate cancer is one of the most common malignant neoplasms in men worldwide, and is
the fifth cause of cancer-related death. In recent years, a new generation of therapies have …

Simple Summary This research has been suggested after a gap was found in the previous
literature, and our hypothesis of the MMR vaccine being an oncolytic virus. The present …

The immune system interacts closely with tumors during the disease development and
progression to metastasis. The complex communication between the immune system and …

Background While surgical resection of pancreatic adenocarcinoma provides the only
chance of cure, long-term survival remains poor. Immunotherapy may improve outcomes …

Sipuleucel-T, a therapeutic dendritic-cell vaccine, was Food and Drug Administration–
approved for prostate cancer in 2010. No new immunotherapies for prostate cancer have …